Toxic megacolon from fulminant Clostridium difficile infection induced by topical silver sulphadiazine

Christopher B Tan1, Dhyan Rajan, Mitanshu Shah

  • 1Department of Internal Medicine, Nassau University Medical Center, East Meadow, New York, USA. ctan@numc.edu

BMJ Case Reports
|August 11, 2012
PubMed

Insights

Topical antibiotics, like silver sulphadiazine, can rarely cause Clostridium difficile infection leading to toxic megacolon (TM). This case highlights an unusual presentation of TM without initial diarrhea.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Dermatology

Background:

  • Clostridium difficile infection (CDI) commonly leads to pseudomembranous colitis and toxic megacolon (TM).
  • Systemic antibiotics are the primary risk factor for CDI, while topical antibiotic association is rare.
  • Topical antibiotics can be systemically absorbed through damaged skin, potentially altering gut flora.

Observation:

  • A 60-year-old male with immune-bullous pemphigus vulgaris developed toxic megacolon (TM).
  • The TM was attributed to Clostridium difficile infection (CDI) triggered by topical silver sulphadiazine.
  • The patient's initial presentation lacked diarrhea, complicating the diagnosis.

Findings:

  • Topical silver sulphadiazine use was linked to the development of C. difficile-induced toxic megacolon (TM).
  • The absence of diarrhea as an initial symptom presented a diagnostic challenge.
  • Despite comprehensive medical and surgical management, the patient experienced an unfavorable outcome.

Implications:

  • This case underscores the potential for topical antibiotics to induce severe gastrointestinal complications like TM.
  • Clinicians should consider CDI in patients with toxic megacolon, even with unusual presentations or topical antibiotic exposure.
  • Further research into the systemic absorption and effects of topical antimicrobials on gut microbiota is warranted.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...